Alexion Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Alexion Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report


  • Products Id :- F1D1D45B-610E-4D6E-98C2-C00A7C54B17F
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Alexion Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis

An in-depth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Alexion Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Alexion Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Key Highlights

Alexion Pharmaceuticals (Alexion or 'the company') is a biopharmaceutical company engaged in the innovation, development and commercialization of life-transforming therapeutic products. The company primarily operates in the US, Europe and Asia Pacific. It is headquartered in Cheshire, Connecticut, and employed 2,924 people as on December 31, 2015.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Company Snapshot

Alexion Pharmaceuticals, Inc.: Company Overview

Alexion Pharmaceuticals, Inc.: Overview and Key Facts

Alexion Pharmaceuticals, Inc.: Overview

Alexion Pharmaceuticals, Inc.: Key Facts

Alexion Pharmaceuticals, Inc.: Key Employees

Alexion Pharmaceuticals, Inc.: Key Employee Biographies

Alexion Pharmaceuticals, Inc.: Major Products and Services

Alexion Pharmaceuticals, Inc.: Company History

Alexion Pharmaceuticals, Inc.: Management Statement

Alexion Pharmaceuticals, Inc.: Locations and Subsidiaries

Alexion Pharmaceuticals, Inc.: Key Competitors

Alexion Pharmaceuticals, Inc.: Company Analysis

Alexion Pharmaceuticals, Inc.: Business Description

Alexion Pharmaceuticals, Inc.: SWOT Analysis

Alexion Pharmaceuticals, Inc.: SWOT Overview

Alexion Pharmaceuticals, Inc.: Strengths

Alexion Pharmaceuticals, Inc.: Weaknesses

Alexion Pharmaceuticals, Inc.: Opportunities

Alexion Pharmaceuticals, Inc.: Threats

Alexion Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Alexion Pharmaceuticals, Inc.: Financial Deals Overview

Alexion Pharmaceuticals, Inc.: Targets and Partners

Alexion Pharmaceuticals, Inc.: Top Deals 2013-2017YTD*

Alexion Pharmaceuticals, Inc.: Advisors

Alexion Pharmaceuticals, Inc.: Top Financial Advisors

Alexion Pharmaceuticals, Inc.: Mergers and Acquisitions

Alexion Pharmaceuticals, Inc.: Partnership

Alexion Pharmaceuticals, Inc.: Recent Developments

Alexion Pharmaceuticals, Inc.: News and Events Summary

Alexion Pharmaceuticals, Inc.: Contracts

Alexion Pharmaceuticals, Inc.: Corporate Governance

Alexion Pharmaceuticals, Inc.: Financial Performance

Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events

Alexion Pharmaceuticals, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Figure 2: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size-Value (US$m)

Figure 3: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2013-YTD*2017)

Figure 4: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2013-YTD*2017)

Figure 5: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2013-YTD*2017)

Figure 6: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2013-YTD*2017)

Table 1: Alexion Pharmaceuticals, Inc.: Key Facts

Table 2: Alexion Pharmaceuticals, Inc.: Key Employees

Table 4: Alexion Pharmaceuticals, Inc.: Key Competitors

Table 5: Alexion Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2013-YTD*2017)

Table 6: Alexion Pharmaceuticals, Inc.: M&A Average Deal Size-Value (US$m)

Table 7: Alexion Pharmaceuticals, Inc.: Targets and Partners

Table 8: Alexion Pharmaceuticals, Inc.: Top Deals 2013-2017YTD*

Table 9: Alexion Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 10: Alexion Pharmaceuticals, Inc.: M&A Volume and Value Trend (2013-YTD*2017)

Table 11: Alexion Pharmaceuticals, Inc.: M&A Activity by Geography (2013-YTD*2017)

Table 12: Alexion Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2013-YTD*2017)

Table 13: Alexion Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2013-YTD*2017)

Table 14: Alexion Pharmaceuticals, Inc.: News and Events Summary

Table 15: Alexion Pharmaceuticals, Inc.: Contracts

Table 16: Alexion Pharmaceuticals, Inc.: Corporate Governance

Table 17: Alexion Pharmaceuticals, Inc.: Financial Performance

Table 18: Alexion Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 19: Alexion Pharmaceuticals, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Alexion Pharmaceuticals, Inc.

select a license
Single User License
USD 175 INR 12493
Site License
USD 350 INR 24987
Corporate User License
USD 525 INR 37480

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com